文献速递肺栓塞与肺血管病

SPECT V/Q与CTPA及平面V/Q诊断肺栓塞策略比较的非劣效随机试验

Comparison of three diagnostic strategies for suspicion of pulmonary embolism: planar ventilation/perfusion scan, CT pulmonary angiography and single-photon emission CT ventilation/perfusion scan - a multicentre, non-inferiority randomised controlled trial.
PubMed 文献 · Eur Respir J · 2026-07-23

这项多中心非劣效随机试验将603例疑似急性肺栓塞患者按2:1:1分配至SPECT V/Q、CTPA或平面V/Q诊断策略,主要终点为负向检查后未治疗患者3个月静脉血栓栓塞风险。因招募缓慢和资金限制提前终止,SPECT V/Q策略未证明非劣效,但负向检查后3个月VTE风险仅0.5%。

要点

  • SPECT V/Q策略负向检查后未治疗患者3个月VTE风险为0.5%(1/221)。
  • SPECT V/Q与联合参考臂的3个月VTE风险差异为0.0%(95%CI -1.2-1.3%)。
  • 试验提前终止,未证明SPECT V/Q策略非劣效于参考标准。

核心结论

  • 试验提前终止后,未证明基于SPECT V/Q的诊断策略对肺栓塞诊断参考标准具有非劣效性。
  • 结果提示采用SPECT V/Q诊断策略管理的患者3个月VTE风险较低。
  • 对于临床疑似急性肺栓塞需胸部影像的患者,SPECT V/Q算法可能是临床实践中可靠的替代选择。

研究设计与样本

  • 多中心、非劣效、随机对照试验,按2:1:1分配至SPECT V/Q、CTPA和平面V/Q诊断策略。
  • 共随机603例患者,SPECT V/Q组303例,CTPA组150例,平面V/Q组150例。
  • 主要终点为负向检查后未治疗患者3个月VTE风险,非劣效界值为绝对差异1%。
  • 试验因招募缓慢和资金限制于2024年10月提前终止。

主要发现

  • 肺栓塞诊断率:SPECT V/Q组61/303(20.1%),CTPA组31/150(20.7%),平面V/Q组24/150(16.0%)。
  • 负向检查后未治疗患者3个月VTE风险:SPECT V/Q组0.5%(1/221),CTPA组0.0%(0/107),平面V/Q组0.8%(1/118)。
  • SPECT V/Q与联合参考臂的3个月VTE风险差异为0.0%(95%CI -1.2-1.3%)。

关键数值与推荐

  • 非劣效界值定义为3个月VTE风险绝对差异1%。
  • 主要终点比较SPECT V/Q组与CTPA和平面V/Q联合组。

临床怎么用

  • 在临床疑似急性肺栓塞需胸部影像的患者中,SPECT V/Q算法可能作为可靠替代选择。
  • 采用SPECT V/Q策略且检查阴性未治疗的患者,3个月VTE风险较低。

局限性

  • 试验因招募缓慢和资金限制提前终止。
  • 提前终止可能影响非劣效性结论的把握度。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: While single-photon emission computed tomography (SPECT) ventilation/perfusion (V/Q) has been widely adopted for pulmonary embolism (PE) diagnosis, it is not currently endorsed by clinical guidelines due to insufficient evidence. METHODS: We conducted a non-inferiority randomised trial comparing SPECT V/Q-, computed tomography pulmonary angiography (CTPA)- and planar V/Q-based diagnostic strategies using a 2:1:1 allocation. The primary end-point was the 3-month risk of venous thromboembolism (VTE) in untreated patients with a negative workup, comparing SPECT V/Q to the combined CTPA and planar V/Q arms. A non-inferiority margin of 1% absolute difference in 3-month VTE risk was defined. Secondary outcomes included PE diagnosis rates. The trial ended prematurely in October 2024 due to slow recruitment and funding limitations. RESULTS: From July 2017 to October 2024, 603 patients were randomised. PE was diagnosed in 61/303 (20.1%) in the SPECT V/Q arm, 31/150 (20.7%) in the CTPA arm and 24/150 (16.0%) in the planar V/Q arm. The 3-month VTE risk in patients left untreated after a negative workup was 0.5% (1/221) for SPECT V/Q, 0.0% (0/107) for CTPA and 0.8% (1/118) for planar V/Q. The difference in outcome between SPECT V/Q and the combined arms was 0.0% (95% CI -1.2-1.3%). CONCLUSION: After being prematurely discontinued, this randomised trial did not demonstrate the non-inferiority of a SPECT V/Q-based strategy to reference standards for PE diagnosis. However, the results suggest a low 3-month VTE risk in patients managed using a SPECT V/Q-based diagnostic strategy. Among patients with clinically suspected acute PE requiring chest imaging, a SPECT V/Q-based algorithm might be a reliable alternative in clinical practice.

来源:Eur Respir J,查看原文。版权归原作者所有。

引用

  1. Le Pennec, Le Roux, Robin, et al. Comparison of three diagnostic strategies for suspicion of pulmonary embolism: planar ventilation/perfusion scan, CT pulmonary angiography and single-photon emission CT ventilation/perfusion scan - a multicentre, non-inferiority randomised controlled trial. Eur Respir J. 2026. PMID: 41927066. doi:10.1183/13993003.01742-2025

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。